Novo Nordisk acknowledges UK marketing violation
The Danish drugmaker now acknowledges that ”mistakes were made” after the UK authority PMCPA has issued reprimands for breaching good practice code in the UK.
by albert rønning-andersson & mikkel aabenhus hemmingsen, translated by daniel pedersen
Mistakes were made when a recent webinar about weight loss management took off in front of health professionals.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma sued over misusing trade secrets
For subscribers
